Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer.
about
Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
name
Cost-effectiveness of cetuxima ...... metastatic colorectal cancer.
@ast
Cost-effectiveness of cetuxima ...... metastatic colorectal cancer.
@en
Cost-effectiveness of cetuxima ...... metastatic colorectal cancer.
@nl
type
label
Cost-effectiveness of cetuxima ...... metastatic colorectal cancer.
@ast
Cost-effectiveness of cetuxima ...... metastatic colorectal cancer.
@en
Cost-effectiveness of cetuxima ...... metastatic colorectal cancer.
@nl
prefLabel
Cost-effectiveness of cetuxima ...... metastatic colorectal cancer.
@ast
Cost-effectiveness of cetuxima ...... metastatic colorectal cancer.
@en
Cost-effectiveness of cetuxima ...... metastatic colorectal cancer.
@nl
P2860
P1433
P1476
Cost-effectiveness of cetuxima ...... metastatic colorectal cancer.
@en
P2093
Adriana Camargo Carvalho
Frederico Leal
P2860
P304
P356
10.1371/JOURNAL.PONE.0175409
P407
P577
2017-04-12T00:00:00Z